The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment.
about
Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: current status and future perspectivesUnknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.Head and neck cancer: improving outcomes with a multidisciplinary approach.HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.Programmed cell death ligand 1 as a biomarker in head and neck cancer.PD-L1 expression in tumor tissue and peripheral blood of patients with oral squamous cell carcinoma.Detection of high PD-L1 expression in oral cancers by a novel monoclonal antibody L1Mab-4.Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype.
P2860
Q33884361-D129E234-D5EA-4F9D-BF6C-B86B7DAAAB01Q38735944-08186A21-0269-46E6-9A0D-8DE23DD39924Q39190801-6A2211E9-4E32-4321-815D-D4C8EE6D5C55Q41522410-9C896E78-C204-4BA9-A106-DC6B60E3F38EQ41934319-EF258FCB-898F-4FF0-9837-A2CF289C868EQ47122217-7466EEA8-AB40-4BE3-8CC5-BA966B2974BDQ49713164-C826EC63-79B5-40E6-9294-7FF32F50DBEFQ52647521-85AEF30E-8524-4614-816B-3C60350EA03CQ52655048-AAB08D8E-6265-4094-95C7-0A1048A7C350
P2860
The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment.
@en
type
label
The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment.
@en
prefLabel
The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment.
@en
P2093
P2860
P1433
P1476
The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment.
@en
P2093
Dan P Zandberg
Sara I Pai
Scott E Strome
P2860
P304
P356
10.1016/J.ORALONCOLOGY.2016.08.001
P407
P577
2016-08-05T00:00:00Z